FIELD: pharmaceutical industry, pharmacy. SUBSTANCE: infusion ciprofloxacin solution is stabilized with lactic acid, sodium chloride and buffer system comprising citric acid, sodium hydrophosphate in the following ratio of components, g: ciprofloxacin, 0.2; sodium chloride, 0.9; citric acid, from 0.615 to 1.845; sodium hydrophosphate, from 0.385 to 1.150; lactic acid, 0.00006-0.00012; purified water, up to 100 ml. Invention provides preparing the preparation as solution. EFFECT: improved stabilizing method. 12 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2435583C1 |
| THERAPEUTIC COMPOSITION FOR THE TREATMENT OF OTITIS MEDIA WITH PERFORATION OF THE TYMPANIC MEMBRANE | 2022 |
|
RU2782926C1 |
| LIQUID DOSAGE FORM OF FENSPIRIDE AND PRODUCTION METHOD THEREOF | 2015 |
|
RU2607965C1 |
| NYSTATIN OINTMENT BASED ON POLYMER SHOWING ANTIFUNGAL EFFECT | 2001 |
|
RU2189222C1 |
| COMPOSITION USED FOR TREATMENT OF PATIENTS WITH MIDDLE EAR OTITIS WITH PERFORATION AND METHOD OF COMPOSITION PREPARING | 1996 |
|
RU2165755C2 |
| PROPOFOL STABLE CLEAR COMPOSITIONS | 2001 |
|
RU2257892C2 |
| LIQUID SWEETENER | 2016 |
|
RU2648460C2 |
| ENROFLOXACIN INJECTION OR INFUSION SOLUTION | 1995 |
|
RU2147225C1 |
| PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2138251C1 |
| ENROFLOXACIN BASED TREATMENT OF MASTITIS | 2005 |
|
RU2413514C2 |
